XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 45,757 $ 29,485
General and administrative 14,317 9,683
Total operating expenses 60,074 39,168
Loss from operations (60,074) (39,168)
Other income (expense):    
Interest income 6,365 3,569
Other expense, net (12) (26)
Total other income 6,353 3,543
Net loss (53,721) (35,625)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities (72) 476
Comprehensive loss $ (53,793) $ (35,149)
Net loss per share, basic $ (0.34) $ (1.22)
Net loss per share, diluted $ (0.34) $ (1.22)
Weighted-average shares outstanding, basic 157,943 29,277
Weighted-average shares outstanding, diluted 157,943 29,277